TrialClinical pharmacology in drug development2026

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open-Label, Parallel-Group Study.

Vincent Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.